Skip to main content
SpringerLink
Log in

Immunosuppressant and Cytotoxic Drugs, Toxic and Metabolic Disorders

  • Chapter
Neurological Disorders

Part of the book series: Treatment in Clinical Medicine ((TC MEDICINE))

  • 98 Accesses

Abstract

Immunosuppressant drugs, including steroids, are used in many neurological disorders for which an autoimmune aetiology has been suggested. These conditions include myasthenia gravis (p. 152), polymyositis and dermatomyositis (p. 158), as well as generalised autoimmune diseases which involve the nervous system, including systemic lupus erythematosus and polyarteritis nodosa.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Brewer GJ, Hill GM, Prasad AS, Cossack ZT, Rabbani P (1983) Oral zinc therapy for Wilson’s disease. Arch Intern Med 99: 314–320

    CAS  Google Scholar 

  • Walsh JM (1982) Treatment of Wilson’s disease with trientine (triethylene tetramine). Lancet I: 643–647

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University Department of Neurology, King’s College School of Medicine and Dentistry, and Institute of Psychiatry, London, SE5 9RS, UK

    J. D. Parkes MD, FRCP (Lond.) (Reader in Neurology), D. N. Rushton MD, MRCP (Honorary Consultant Neurologist) & C. D. Marsden DSc, FRCP, FRS (Professor of Neurology)

  2. University Department of Neurology, Institute of Psychiatry, London, SE5 8AF, UK

    P. Jenner BPharm, PhD, MPS (Reader in Neurochemical Pharmacology)

Authors
  1. J. D. Parkes MD, FRCP (Lond.)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Jenner BPharm, PhD, MPS
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. N. Rushton MD, MRCP
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. D. Marsden DSc, FRCP, FRS
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Parkes, J.D., Jenner, P., Rushton, D.N., Marsden, C.D. (1987). Immunosuppressant and Cytotoxic Drugs, Toxic and Metabolic Disorders. In: Neurological Disorders. Treatment in Clinical Medicine. Springer, London. https://doi.org/10.1007/978-1-4471-3140-3_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-3140-3_8

  • Publisher Name: Springer, London

  • Print ISBN: 978-3-540-17013-6

  • Online ISBN: 978-1-4471-3140-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation